---

A study of serum magnesium and dyslipidemia in type 2 diabetes mellitus patients

---

Null

Author Details : Netravathi Sajjan, Mohammed Shamsuddin

Volume : 3, Issue : , Year : 2016

Article Page : 36-41

Suggest article by email

Get Permission

---

Abstract

Background: Type 2 diabetes is a heterogeneous metabolic disease characterised by insulin resistance in peripheral tissue together with impaired insulin secretion. It affects more than 285 million peoples worldwide and estimated that it will affect more than 438 million by the year 2030. It is the leading cause of morbidity and mortality. Magnesium is an important intracellular cation. Hypomagnesaemia is associated with diabetes. Dyslipidemia is seen in Diabetes mellitus.
Objectives: To estimate serum magnesium and lipid profile in type 2 diabetes mellitus patients and controls. To correlate serum Magnesium level with lipid profile in type 2 diabetes mellitus patients.
Materials & methods: A total of 100 subjects were included, out of which 50 were cases and 50 were controls. Fasting blood sugar (FBS), serum magnesium and lipid profile were measured. Data was statistically analyzed using SPSS 17^thversion.
Results: There was statistical significant difference of serum Magnesium levels 1.56mg/dI due to hyperglycemia induced osmotic diuresis , Total cholesterol (TC), Triglycerides, Low density lipoprotein(LDL) and High density lipoprotein(HDL) due to increased flux of free fatty acids to liver secondary to insulin resistance was observed in Type 2 diabetes when compared with healthy controls. Significant negative correlation was observed between serum magnesium with Fasting blood glucose, TC, Triglycerides and LDL. Significant positive correlation was observed between serum magnesium and HDL levels.
Conclusion: Hypomagnesaemia has role in perturbation of lipid metabolism in diabetics.

Keywords: Fasting Blood Sugar, Dyslipidemia, Serum Magnesium

How to cite : Sajjan N, Shamsuddin M, A study of serum magnesium and dyslipidemia in type 2 diabetes mellitus patients. Int J Clin Biochem Res 2016;3():36-41

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.